BRAF and melanoma: Melanomas which are wild type for BRAF, NRAS, and NF1 show amplifications of KIT, platelet-derived growth factor receptor α (PDGFRA), and vascular endothelial growth factor receptor 2 (VEGFR2) in 10–20% of cases [5].